| 16th Aug 2019 7:00 am |
RNS |
Change of Adviser |
| 8th Aug 2019 2:17 pm |
RNS |
Sareum notes Sierra Q2 results |
| 29th Jul 2019 4:29 pm |
RNS |
Additional disclosure concerning Michael Owen |
| 28th Jun 2019 7:00 am |
RNS |
Additional Funds Raised |
| 27th Jun 2019 1:50 pm |
RNS |
Sierra seeks strategic options for SRA737 |
| 26th Jun 2019 7:00 am |
RNS |
Successful Fundraising |
| 25th Jun 2019 4:31 pm |
RNS |
PrimaryBid.com Offer |
| 25th Jun 2019 4:30 pm |
RNS |
Placing to progress TYK2/JAK1 programmes |
| 13th Jun 2019 7:00 am |
RNS |
Portfolio Update |
| 3rd Jun 2019 4:00 pm |
RNS |
Key takeaways from SRA737 webcast at ASCO |
| 3rd Jun 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
| 3rd Jun 2019 11:00 am |
RNS |
Price Monitoring Extension |
| 3rd Jun 2019 7:00 am |
RNS |
Positive SRA737 data presented at ASCO |
| 16th May 2019 7:00 am |
RNS |
ASCO abstracts for SRA737 published |
| 8th May 2019 12:41 pm |
RNS |
Sareum notes Sierra Oncology Q1 2019 Results |
| 30th Apr 2019 7:00 am |
RNS |
Sareum to Present at BioTrinity 2019 in London |
| 23rd Apr 2019 7:00 am |
RNS |
SRA737 Phase I/IIa data to be presented at ASCO |
| 2nd Apr 2019 7:00 am |
RNS |
Preclinical Data for SRA737 Presented at AACR 2019 |
| 12th Mar 2019 7:00 am |
RNS |
Sareum Holdings PLC Issue of Options |
| 4th Mar 2019 7:00 am |
RNS |
HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018 |
| 28th Feb 2019 2:04 pm |
RNS |
Sierra Oncology has reported its 2018 Results |
| 28th Feb 2019 8:14 am |
RNS |
New SRA737 preclin data to be presented at AACR |
| 23rd Jan 2019 1:38 pm |
RNS |
Sierra Oncology to present SRA737 at DDR Tx Summit |
| 18th Dec 2018 12:35 pm |
RNS |
Results of AGM |
| 18th Dec 2018 7:00 am |
RNS |
AGM Statement |
| 30th Nov 2018 11:17 am |
RNS |
Amendment to Preclinical Efficacy Announcement |
| 30th Nov 2018 7:45 am |
RNS |
Preclinical Efficacy for Immunotherapy Combination |
| 15th Nov 2018 10:24 am |
RNS |
Preclinical Data for SRA737 in Ovarian Cancer |
| 14th Nov 2018 7:00 am |
RNS |
AGM NOTICE |
| 13th Nov 2018 7:00 am |
RNS |
Directorate Change |
| 8th Nov 2018 12:28 pm |
RNS |
Sierra Oncology Q3 2018 Results |
| 26th Oct 2018 7:00 am |
RNS |
Completion of Placing |
| 1st Oct 2018 7:00 am |
RNS |
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018 |
| 27th Sep 2018 1:03 pm |
RNS |
Notice of Results |
| 26th Sep 2018 7:00 am |
RNS |
TYK2/JAK1 selected for certain cancers |
| 11th Sep 2018 7:00 am |
RNS |
Pre-Close Trading Statement |
| 10th Sep 2018 7:00 am |
RNS |
Selection of TYK2/JAK1 for autoimmune diseases |
| 9th Aug 2018 1:15 pm |
RNS |
Sareum notes Sierra Oncology Q2 2018 Results |
| 11th Jul 2018 9:38 am |
RNS |
Notification of PCA Shareholding |
| 15th Jun 2018 7:00 am |
RNS |
Advisers |
